SEPAWA Congress 2025: Seppic targets demand for non-invasive skin care treatments
17 Oct 2025 | Seppic
Seppic tells us on the show floor of the SEPAWA Congress 2025 about its biotech active ingredient: Celtosome Eryngium Maritimum. It is derived from plant cell cultures and designed to provide skin rejuvenation by boosting the skin’s natural hyaluronic acid synthesis. The solution caters to the growing consumer demand for high-efficacy, low-invasive treatments. Claire Liu, global market and digital manager, Beauty Care at Seppic tells us the active could be an alternative to consumers seeking hyaluronic acid injections.
This is Beatrice Wilander for Personal Care Insights.
I am here at the Sepawa T 25 in Berlin, Germany.
I am with Claire Liu, market and digital manager for beauty care at SEPI.
Welcome.
Can you tell us what you're showcasing today?
Today we are showcasing mainly our active ingredients.
So it is a biotech wrinkle filler from plant cell culture.
So it's an active ingredient with the inky filtrate.
It is used at a recommended level of just 0.05%.
And what is interesting about this ingredient is that it plumps and fills the wrinkles from the inside.
So you have results about dermis reinforcement and skin plumping, and maybe if you have to keep in mind one big result is that it more than doubles the skin hyaluronic acid synthesis, it more than doubles the synthesis with a 103% increase versus placebo.
And skin explants.
So you mentioned that it has a double effects from hyaluronic acid.
Does it have any other benefits for the skin?
It also, it has a dermis reinforcement effects.
It has skin plumping with the hyaluronic acid, but it also has dermis reinforcement, so it will increase the synthesis of collagen and elastin.
And also the ingredient is rich in exosomes, so it contains exosomes.
We have beautiful images about that and also we have very good results.
We made a clinical trial on 62 volunteers who had CrossFit wrinkles, and so one group had to apply the cream with.
0.05% of the ingredients for 28 days and the other group had a placebo and we see very good results on wrinkle length, wrinkle area, and wrinkle volume, and it really smooths the Kraus fin wrinkle area.
And what cosmetic formulation is this ingredient applicable for, I guess skincare, but is it also for haircare or for makeup?
So this ingredient is really made for skincare and maybe makeup, but really it's about the finished product that wants to claim dermis plumping.
Skin hyaluronic acid boosting or wrinkle filling, and it's really about products that wants to respond to consumer demands about non-invasive procedures because consumers are really looking for high efficacy but non-invasive procedures, so it will maybe be a good alternative to injections, for example.
All right, and can you share more about the biotechnology behind this product?
Yes, so the biotechnology is called celtosome.
That's why our ingredient is celtosome erang masimum, and this biotechnology is based.
Based on a plant cell culture, so from only a few seeds, actually one seed of marisimum, we will be able to produce the whole cells of the ingredients.
So.
Just one seed we will grow a callus and this callous will be put on a culture medium.
It will then be multiplied.
The cells will multiply and then first at a lab scale and then scaled up in a bioreactor and it will be stirred and it will grow.
And when the, the cells are multiplied enough, we will filtrate it and liophyize it.
So then we obtain a powder, like a a very high concentrated powder.
And this is the final ingredient and thanks to a a quality tool that we have that is cell counting, we will be able to get the potency of these ingredients and it is really tangible because for example, when you have a finished product, a finished cream containing just 0.05% of the ingredients.
You will have a density of about 50,000 cells per gram, and as I said, it's rich in exosomes, and what maybe I could add about this biotechnology is that it will prevent us from using, we will preserve the soils because we won't have to grow the plants and actually it's A protected plant.
So without this biotechnology we wouldn't be able to use it.
And what are your expectations of biotech's role in the future of the personal care industry?
One thing that we can see is that consumers are really looking for sustainable sourcing but also high efficacy.
And in the past it was quite separate, but now we see that consumers really want a convergence between both, and this gives a big place for biotechnology since it will help for the sustainability without all the sourcing to thanks to preservation of soils and also the high efficacy.
But the thing is, for now we also see that biotech beauty is not that common.
The term is not always completely clear for consumers, so I think that the industry, our industry, has a very big potential about this to educate consumers.
